Have your own idea? Try our Stock Screener
UPDATED Jan 31, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
BHC | US$7.43 | -3.8% | -6.2% | US$2.7b | US$9.33 | PE-15.4x | E218.2% | n/a | ||
SBFM | US$2.85 | -0.6% | -99.4% | US$5.5m | US$300.00 | PB0.2x | E208.2% | n/a | ||
AMRX | US$8.26 | -4.8% | 49.6% | US$2.7b | US$10.50 | PE-13.9x | E154.7% | 0% | ||
CDMO | US$12.48 | 0.5% | 101.3% | US$797.0m | US$12.88 | PS5.3x | E147.8% | n/a | ||
SNDL | US$1.74 | -0.6% | 27.9% | US$480.6m | US$3.18 | PB0.6x | E144.4% | n/a | ||
AZTA | US$54.05 | -0.2% | -18.2% | US$2.5b | US$59.00 | PS3.8x | E125.6% | 0% | ||
EVOK | US$4.97 | 12.7% | -40.9% | US$9.6m | US$18.00 | PS1.2x | E124.7% | n/a | ||
MLAB | US$137.69 | -2.0% | 46.5% | US$772.6m | US$133.33 | PS3.3x | E124.7% | 0.5% | ||
ORGO | US$3.68 | 3.4% | 10.5% | US$474.0m | US$5.00 | PS1x | E123.4% | n/a | ||
PLX | US$2.43 | -1.2% | 67.6% | US$175.2m | US$14.00 | PS3.9x | E118.3% | n/a | ||
EBS | US$11.25 | -3.5% | 594.4% | US$602.0m | US$13.50 | PB1.2x | E117.1% | n/a | ||
ANIK | US$17.06 | 4.6% | -26.1% | US$253.1m | US$26.50 | PS1.5x | E108.3% | n/a | ||
IRWD | US$2.34 | -36.9% | -84.0% | US$368.1m | US$9.20 | PE-152x | E108.0% | n/a | ||
AQB | US$0.72 | -22.5% | -72.0% | US$2.7m | US$1.00 | PS2.2x | E105.9% | n/a | ||
ENSC | US$6.87 | -9.3% | -70.2% | US$8.8m | US$52.25 | PS2x | E102.6% | n/a | ||
CSBR | US$10.99 | -5.3% | 84.7% | US$146.6m | US$8.00 | PS2.8x | E101.4% | n/a | ||
ALVO | US$12.72 | -2.1% | -19.0% | US$3.7b | US$17.40 | PS9.7x | E99.0% | n/a | ||
VNDA | US$4.41 | 0.2% | 21.5% | US$267.1m | US$12.17 | PS1.3x | E95.9% | n/a | ||
NTRB | US$8.29 | -2.8% | 197.1% | US$87.7m | US$13.00 | PS45.5x | E94.3% | n/a | ||
CDNA | US$23.30 | 4.3% | 167.2% | US$1.2b | US$32.86 | PS4x | E94.3% | n/a | ||
HBIO | US$1.71 | -1.7% | -62.2% | US$77.2m | US$6.25 | PB1.1x | E89.4% | n/a | ||
AYTU | US$1.67 | -2.1% | -36.9% | US$10.3m | US$8.00 | PB0.3x | E84.7% | n/a | ||
NBY | US$0.67 | -7.3% | -88.3% | US$3.2m | n/a | PB3.1x | E84.5% | n/a | ||
SYBX | US$1.39 | -2.8% | -59.2% | US$16.3m | US$1.00 | PS5.9x | E82.9% | n/a |